Literature DB >> 12361421

Failed pilonidal surgery: new paradigm and new operation leading to cures.

John Bascom, Thomas Bascom.   

Abstract

HYPOTHESIS: Refractory pilonidal disease is due to damage of the epidermis in the deep gluteal cleft by moisture and bacteria, rather than to damage in deep tissues. A new paradigm suggests that a procedure to change the shape of the gluteal cleft will improve results.
DESIGN: Before-and-after trial.
SETTING: Community private practice with extensive experience in pilonidal disease, providing ambulatory and hospital care. PATIENTS: Thirty-one patients with severe refractory pilonidal disease, with a median follow-up of 20 months in 27 patients (87%). Patients had undergone a total of 141 operations with wounds still open for a combined total of 252 years. INTERVENTION: The deep gluteal cleft was reshaped with a skin flap. Deep tissue was left essentially intact. MAIN OUTCOME MEASURES: Number healed, time to healing, number of operations required.
RESULTS: Wounds in all 31 patients healed, 28 after a single procedure. The time to healing was rapid, within 1 week in 22 patients. There were no recurrences.
CONCLUSIONS: For refractory pilonidal disease, the cleft lift procedure produced rapid results by drawing intact skin over the cleft and bringing the suture line out to open air. The failures of old methods and success of this new one suggest a need for a paradigm shift in our understanding of pilonidal disease. The source of disease is not the deep tissue but rather the epidermis in the moist, hypoxic, and bacteria-laden gluteal cleft. This also has implications for initial treatment of pilonidal disease, where simple, nonoperative treatments are often effective.

Entities:  

Mesh:

Year:  2002        PMID: 12361421     DOI: 10.1001/archsurg.137.10.1146

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  40 in total

1.  Lateral incision surgery for pilonidal sinus: death of a dogma.

Authors:  Mark Cheetham
Journal:  World J Surg       Date:  2012-02       Impact factor: 3.352

2.  Pilonidal disease.

Authors:  Amit Khanna; John L Rombeau
Journal:  Clin Colon Rectal Surg       Date:  2011-03

3.  The treatment of pilonidal disease: guidelines of the Italian Society of Colorectal Surgery (SICCR).

Authors:  D Segre; M Pozzo; R Perinotti; B Roche
Journal:  Tech Coloproctol       Date:  2015-09-16       Impact factor: 3.781

4.  Karydakis flap for recurrent pilonidal disease.

Authors:  Igors Iesalnieks; Sina Deimel; Hans J Schlitt
Journal:  World J Surg       Date:  2013-05       Impact factor: 3.352

5.  A new approach: oblique excision and primary closure in the management of acute pilonidal disease.

Authors:  Fatih Ciftci; Ibrahim Abdurrahman; Mirhan Tosun; Gurhan Bas
Journal:  Int J Clin Exp Med       Date:  2014-12-15

6.  Is the cleft lift procedure for non-acute sacrococcygeal pilonidal disease a definitive treatment? Long-term outcomes in 74 patients.

Authors:  P M Ortega; J Baixauli; J Arredondo; M Bellver; C Sánchez-Justicia; S Ocaña; J L Hernández-Lizoain
Journal:  Surg Today       Date:  2014-05-21       Impact factor: 2.549

7.  Fascio-Adipo-Cutaneous Lateral Advancement Flap for Treatment of Pilonidal Sinus: A Modification of the Karydakis Operation-Cohort Study.

Authors:  Mohammad Hamdy Abo-Ryia; Hamdy Sedky Abd-Allah; Mahmoud Moustafa Al-Shareef; Mahmoud Mohammed Abdulrazek
Journal:  World J Surg       Date:  2018-06       Impact factor: 3.352

8.  Modified Primary Closure Method for the Treatment of Pilonidal Sinus.

Authors:  Sukru Arslan; Erdem Karadeniz; Gurkan Ozturk; Bulent Aydinli; Muhammed Cagri Bayraktutan; Sabri Selcuk Atamanalp
Journal:  Eurasian J Med       Date:  2016-06

Review 9.  German national guideline on the management of pilonidal disease.

Authors:  I Iesalnieks; A Ommer; S Petersen; D Doll; A Herold
Journal:  Langenbecks Arch Surg       Date:  2016-06-16       Impact factor: 3.445

10.  Pilonidal disease.

Authors:  Franklin P Bendewald; Robert R Cima
Journal:  Clin Colon Rectal Surg       Date:  2007-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.